HomeInvestment Pitch FSD Pharma signs binding LOI to acquire NASDAQ-listed Therapix Biosciences
FSD Pharma signs binding LOI to acquire NASDAQ-listed Therapix Biosciences
Investment Pitch | Season 1
Therapix is currently repurposing an FDA-approved cannabinoid for the treatment of central nervous system disorders, sleep disorders, pain management, mild cognitive impairment, traumatic brain injury and infectious diseases.